Johnson & Johnson: Rhinitis trials

The registry lists 10 Rhinitis studies with Johnson & Johnson as lead sponsor. 0 are open to participants now and 2 have results posted.

Early Phase 1 1Phase 1 4Phase 2 3Phase 4 2(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Study of a Topical Nasal Spray to Ease the Symptoms of HayfeverCompletedNCT01500629Early Phase 1Results posted
• An Efficacy Study of JNJ-39220675 and Pseudoephedrine in Participants With Allergic RhinitisCompletedNCT00804687Phase 2Results posted
• A Study of Intranasal Budesonide Aqueous Spray for Treatment of Rhinitis During Periods of High Airborne PollutionCompletedNCT04132570Phase 4
• Randomized, Double Blind, Parallel Group, Placebo Controlled, Multi-Center Study of the Efficacy and Safety of Cetirizine HCl Syrup vs. Loratadine Syrup vs. Placebo in Treatment of Children With Seasonal Allergic Rhinitis (SAR)CompletedNCT02932774Phase 4
• Study to Assess the Effects of Allergic Rhinitis and Co-administration of Mometasone or Oxymetazoline on the Pharmacokinetics, Safety, and Tolerability of Intranasal EsketamineCompletedNCT02154334Phase 1
• Vienna Challenge Chamber Study Using RV658 in Subjects With Allergic RhinitisCompletedNCT01230619Phase 2
• A Single and Multiple Dose Study to Explore the Safety of JNJ-38224342 in Healthy Patients and Patients With Seasonal AllergiesCompletedNCT01054352Phase 1
• Study to Evaluate Diphenhydramine in Children and AdolescentsCompletedNCT00762749Phase 1
• Phenylephrine Pediatric Pharmacokinetic StudyCompletedNCT00762567Phase 1
• A Study Evaluating Effects of Intranasal JNJ-17166864 on Symptoms of Allergic Rhinitis in AdultsCompletedNCT00604123Phase 2